West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) declared a quarterly dividend on Thursday, April 25th, Zacks reports. Investors of record on Wednesday, July 31st will be given a dividend of 0.20 per share by the medical instruments supplier on Wednesday, August 7th. This represents a $0.80 annualized dividend and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, July 31st.
West Pharmaceutical Services has increased its dividend payment by an average of 5.8% per year over the last three years and has increased its dividend every year for the last 31 years. West Pharmaceutical Services has a payout ratio of 10.1% indicating that its dividend is sufficiently covered by earnings. Equities research analysts expect West Pharmaceutical Services to earn $8.95 per share next year, which means the company should continue to be able to cover its $0.80 annual dividend with an expected future payout ratio of 8.9%.
West Pharmaceutical Services Stock Performance
WST opened at $288.12 on Tuesday. The stock has a market capitalization of $20.90 billion, a price-to-earnings ratio of 38.01, a PEG ratio of 6.13 and a beta of 1.00. The company has a fifty day moving average of $322.99 and a 200 day moving average of $355.32. West Pharmaceutical Services has a fifty-two week low of $265.00 and a fifty-two week high of $415.73. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.68 and a current ratio of 2.34.
Insiders Place Their Bets
In other West Pharmaceutical Services news, CEO Eric Mark Green sold 66,000 shares of West Pharmaceutical Services stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total value of $24,198,900.00. Following the completion of the transaction, the chief executive officer now directly owns 152,908 shares of the company’s stock, valued at approximately $56,063,718.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other West Pharmaceutical Services news, CEO Eric Mark Green sold 66,000 shares of West Pharmaceutical Services stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $366.65, for a total value of $24,198,900.00. Following the completion of the transaction, the chief executive officer now directly owns 152,908 shares of the company’s stock, valued at approximately $56,063,718.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Silji Abraham sold 1,800 shares of West Pharmaceutical Services stock in a transaction on Wednesday, June 12th. The stock was sold at an average price of $330.78, for a total transaction of $595,404.00. Following the completion of the transaction, the senior vice president now directly owns 2,860 shares of the company’s stock, valued at $946,030.80. The disclosure for this sale can be found here. Corporate insiders own 0.53% of the company’s stock.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Featured Stories
- Five stocks we like better than West Pharmaceutical Services
- Investing in Commodities: What Are They? How to Invest in Them
- Why This Manufacturer is Committing to a Massive Buyback Program
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Top 2 Cheap Healthcare Stocks to Buy as Sector Outperforms
- What is the Euro STOXX 50 Index?
- Healthcare Stock Rides the Acute Services Phenomenon to New Highs
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.